Noel Ellison
Noel Ellison publishes mostly in Psychiatry and Mental health, Pharmacology and Neurology, on topics such as Dementia and Cognitive Impairment Research, Cholinesterase and Neurodegenerative Diseases and Attention Deficit Hyperactivity Disorder.
- World rank
- #2,752,153 of 7,710,434 ranked researchers
- Rank in United States
- #800,691 of 1,627,098
- Works
- 41
- Citations
- 1.1k
- Citations per work
- 26.9
What does Noel Ellison research?
Noel Ellison's work is mostly in Medicine (47%), Neuroscience (12%), Computer Science (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1947.3%
- Medicine1947.3%
- Everything else1435.1%
- Life Sciences512.2%
- Neuroscience512.2%
- Physical Sciences25.4%
- Computer Science25.4%
- 1Psychiatry and Mental health27% of their works
- 2Pharmacology16% of their works
- 3Neurology7% of their works
- 4Artificial Intelligence5% of their works
- 5Cognitive Neuroscience5% of their works
- 6Endocrinology, Diabetes and Metabolism4% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Cholinesterase and Neurodegenerative Diseases
- Attention Deficit Hyperactivity Disorder
- Neurological Disorders and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Computational Drug Discovery Methods
- Statistical Methods in Clinical Trials
- Alzheimer's disease research and treatments
Which keywords describe Noel Ellison's research?
The keywords of their largest research topics: Alzheimer's Disease, Biomarkers, Dementia, Mild Cognitive Impairment, Acetylcholinesterase, Cholinesterase Inhibitors, ADHD and Attention-Deficit/Hyperactivity Disorder.
- Tau Pathology
- False Discovery Rate
- Adaptive Designs
- Cost-effectiveness Analysis
- Cerebrolysin
- Attention-Deficit/Hyperactivity Disorder
- Cholinesterase Inhibitors
- Mild Cognitive Impairment
- Biomarkers
- Alzheimer's Disease
- Dementia
- Acetylcholinesterase
- ADHD
- Oxidative Stress
- Citicoline
- Quality of Life
- Amyloid Hypothesis
- Molecular Docking
- Virtual Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Alzheimer's Disease303 topics
- Biomarkers162 topics
- Dementia141 topic
- Mild Cognitive Impairment141 topic
- Acetylcholinesterase121 topic
- Cholinesterase Inhibitors121 topic
- ADHD61 topic
- Attention-Deficit/Hyperactivity Disorder61 topic
- Oxidative Stress62 topics
- Cerebrolysin41 topic
- Citicoline41 topic
- Cost-effectiveness Analysis31 topic
- Quality of Life31 topic
- Adaptive Designs21 topic
- Amyloid Hypothesis21 topic
- False Discovery Rate21 topic
- Molecular Docking21 topic
- Tau Pathology21 topic
- Virtual Screening21 topic
Where does Noel Ellison work?
Noel Ellison's main affiliation in the publication record is TetraLogic Pharmaceuticals (United States), United States.
How many publications and citations does Noel Ellison have?
OpenAlex counts 41 works and 1,101 citations for Noel Ellison, an h-index of 8, ranking #2,752,153 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Noel Ellison. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.